期刊文献+

原发性高血压条件下骨髓来源内皮祖细胞数量及功能的变化 被引量:5

Number and function of bone marrow-derived endothelial progenitor cells in essential hypertension
下载PDF
导出
摘要 目的了解原发性高血压对体外培养骨髓来源内皮祖细胞(EPC)数量及功能的影响。方法将自发性高血压大鼠(SHR)分为6、12周龄组,以同周龄正常血压Wistar-Kyoto(WKY)大鼠为对照。以密度梯度离心法分离骨髓来源单个核细胞体外培养,差速贴壁法培养7 d后收集贴壁细胞并行鉴定为骨髓来源内皮祖细胞,测定EPC数量、细胞增殖活力(MTT法)、NO分泌及细胞凋亡率。结果 6周龄SHR骨髓来源EPC数量与6周龄WKY大鼠比较差异无统计学意义(P>0.05),细胞增殖能力、NO分泌能力受损(P<0.05),凋亡率稍增多但差异无统计学意义(P>0.05)。12周龄SHR骨髓来源EPC数量与12周龄WKY大鼠比较明显减少(P<0.01),细胞增殖能力、NO分泌能力受损(P<0.01),凋亡增多(P<0.05)。结论随着SHR血压升高和原发性高血压病程延长,骨髓来源内皮祖细胞数量减少,功能减退,凋亡增多。 Objective To evaluate the effect on number and function of endothelial progenitor cells in essential hypertension condition. Methods Mononuclear cells of 6-week and 12-week spontaneously hypertensive rats (SHR) from rat bone marrows were isolated by density gradient centrifugation, and age matched Wistar-Kyoto rats (WKY) were used as controls. After 7 d cultivation, adhering cell, and identified the cell to be EPC were harvested by FITC-UEA-1 and Dil-ac-LDL double staining. Number of EPC were counted, and detected proliferative capacity, NO secretion and apoptosis rate of EPC. Results There was no significant difference (P 〉 0.05) of bone marrow-derived EPC number between 6-week SHR and 6-week WKY, the capacity of proliferation and NO secretion were impaired (P 〈 0.05), rate of cell apoptosis was unremarkablely higher than that of controls (P 〉 0.05). While EPC number of 12-week SHR was much less than 12-week WKY. The capacity of proliferation and NO secretion were significantly impaired (P 〈 0.01), rate of cell apoptosis was higher than control (P 〈 0.05). Conclusion In accordance with the development of high blood pressure and hypertension progress, number of bone marrow-derived EPC become less and the function of EPC are impaired.
出处 《中国医药导报》 CAS 2013年第7期20-21,24,共3页 China Medical Herald
关键词 原发性高血压 内皮祖细胞 大鼠 Essential hypertension Endothelial progenitor cells Rat
  • 相关文献

参考文献6

  • 1Werner N, Nickenig G. Clinical and therapeutical implication of EPC biology in atheroselerosis [J]. J Cell Mol Med,2006,10(2):318-332.
  • 2Hill JM ,Zalos G,Haleox JP,et al. Circulating endothelial progenitor cells,vascular function,and cardiovascular risk [J]. N Engl J Med, 2003,348(7) : 593-600.
  • 3Gensch C,Clever YP,Werner C ,et al. The PPAR-gamma agonist pi- oglitazone increases neoangiogenesis and prevents apoptosis of en- dothelial progenitor eells. Atherosclerosis, 2006, (192) : 67-74.
  • 4Shirota T,He H,Yasui H,et al. Human endothdial progenitor cell- seeded hybrid graft:proliferative and antithrombogenic potentials in vitro and fabrication processing [J]. Tissue Eng,2003,9( 1 ) : 127-136.
  • 5Vasa M ,Fichtlscherer S,Aicher A ,et al. Number and migratory activ- ity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease [J]. Circ Res,2001,89( 1 ) : 1-7.
  • 6刘燕荣,陈君柱,王兴祥,朱军慧,谢旭东,孙坚.冠心病患者外周血内皮祖细胞数量和功能的变化[J].临床心血管病杂志,2004,20(3):145-147. 被引量:3

二级参考文献9

  • 1[1]Asahara T, Murohara T, Sullivan A, et al. Isolation of putative endothelial progenitor cells for angiogenesis. Science, 1997, 275: 964-967.
  • 2[2]Peichev M, Naiyer A J, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood,2000, 95: 952-958.
  • 3[3]Walter D H, Rittig K, Bahlmann F H, et al. Statin therapy accelerate reendothelialization.Circulation, 2002, 105:3017-3024.
  • 4[4]Hill J M, Zalos G, Halcox J P, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med, 2003, 348:593-600.
  • 5[5]Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells Inversely correlate with risk factors for coronary artery disease. Cir Res,2001, 89: E1-7.
  • 6[6]Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA, 2000, 97: 3422-3427.
  • 7[7]Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation, 2001, 103: 2885-2890.
  • 8[8]Murohara T, Tepper O, Silver M, et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization. Exp Hematol, 2002,30:967-967.
  • 9[9]Suzuki T, Nishida M, Futami S, et al. Neoendothelialization after peripheral blood stem cell transplantation in humans. A case report of a Tokaimura nuclear accident victim. Cardiovasc Res, 2003,58:487-492.

共引文献2

同被引文献45

  • 1刘星,张高星,夏文豪,杨震,陶军.高血压对内皮祖细胞再内皮化能力的影响[J].中国分子心脏病学杂志,2011,11(1):23-25. 被引量:5
  • 2Macarthur JW,Purcell BP,Shudo Y,et al. Sustained re- lease of engineered stromal cell-derived factor 1-or from injectable hydrogels effectively recruits endothelial pro- genitor cells and preserves ventricular function after myo- cardial infarction [J]. Circulation ,2013,128 (11 Suppl 1 ) : 79-86.
  • 3Yu X,Seegar TC ,Dalton AC ,et al. Structural basis for an- giopoietin-l-mediated signaling initiation [J]. Proc Natl Acad Sci USA,2013,110(18) :7205-7210.
  • 4Fernandes T,Nakamuta JS, Magalhaes FC,et al. Exercise training restores the endothelial progenitor cells number and function in hypertension:implications for angiogenesis [J]. J Hypertens, 2012,30( 11 ) : 2133-2143.
  • 5Song Y,Wang Z,Liu L,et al. The level of circulating endothelial progenitor cells May be associated with the occurrence and recurrence of chronic subdural hematoma [J] Clinics (Sao Paulo) ,2013,68(8) : 1084-1088.
  • 6Sobrino T, Blanco M, Prrez-Mato M, et al. Increased lev- els of circulating endothelial progenitor cells in patients with ischaemic stroke treated with statins during acute phase [J]. Eur J Neurol,2012,19(12) : 1539-1546.
  • 7Cacciatore F, Bruzzese G, Vitale DF, et al. Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients [J]. Eur J Clin Pharmacol, 2011,67 (9) : 877-883.
  • 8Gu A,Shively JE. Angiopoietins-1 and -2 play opposing roles in endothelial sprouting of embryoid bodies in 3D culture and their receptor Tie-2 associates with the cell- cell adhesion molecule PECAM1 [J]. Exp Cell Res,2011, 317 (15) : 2171-2182.
  • 9Oliveras A,Soler MJ,Martinez-Estrada OM,et al. Endothelialprogenitor cells are reduced in refractory hypertension[ J]. J HumHypertens, 2008,22: 183-190.
  • 10Imanishi T, Moriwaki C, Hano T, et al. Endothelial progenitorcell senescence is accelerated in both experimental hypertensiverats and patients with essential hypertension[ J]. J Hypertens,2005, 23: 1831-1837.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部